Ligand‐Mediated Magnetism‐Conversion Nanoprobes for Activatable Ultra‐High Field Magnetic Resonance Imaging
Authors:
- 24 January 2024
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (10) , e202318948
Abstract
Ultra‐high field (UHF) magnetic resonance imaging (MRI) has emerged as a focal point of interest in the field of cancer diagnosis. Despite the ability of current paramagnetic or superparamagnetic smart MRI contrast agents to selectively enhance tumor signals in low‐field MRI, their effectiveness at UHF remains inadequate due to inherent magnetism. Here, we report a ligand‐mediated magnetism‐conversion nanoprobe (MCNP) composed of 3‐mercaptopropionic acid ligand‐coated silver‐gadolinium bimetallic nanoparticles. The MCNP exhibits a pH‐dependent magnetism conversion from ferromagnetism to diamagnetism, facilitating tunable nanomagnetism for pH‐activatable UHF MRI. Under neutral pH, the thiolate (−S−) ligands lead to short τ′m and increased magnetization of the MCNPs. Conversely, in the acidic tumor microenvironment, the thiolate ligands are protonated and transform into thiol (−SH) ligands, resulting in prolonged τ′m and decreased magnetization of the MCNP, thereby enhancing longitudinal relaxivity (r1) values at UHF MRI. Notably, under a 9 T MRI field, the pH‐sensitive changes in Ag−S binding affinity of the MCNP lead to a remarkable (>10‐fold) r1 increase in an acidic medium (pH 5.0). In vivo studies demonstrate the capability of MCNPs to amplify MRI signal of hepatic tumors, suggesting their potential as a next‐generation UHF‐tailored smart MRI contrast agent.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFB3203801, 2022YFB3203804, 2022YFB3203800)
- National Natural Science Foundation of China (32071374, 22305151)
- Natural Science Foundation of Zhejiang Province (LR22C100001)
- Innovative Research Team of High-level Local University in Shanghai (SHSMU-ZDCX20210900)
This publication has 55 references indexed in Scilit:
- Nano Ultrasound Contrast Agent for Synergistic Chemo‐photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and MetastasisAdvanced Science, 2023
- Ternary Alloy PtWMn as a Mn Nanoreservoir for High‐Field MRI Monitoring and Highly Selective Ferroptosis TherapyAngewandte Chemie International Edition, 2022
- Dynamically switchable magnetic resonance imaging contrast agentsExploration, 2021
- A Nature‐Inspired Metal–Organic Framework Discriminator for Differential Diagnosis of Cancer Cell SubtypesAngewandte Chemie International Edition, 2021
- Quantitative Mapping of Glutathione within Intracranial Tumors through Interlocked MRI Signals of a Responsive NanoprobeAngewandte Chemie International Edition, 2020
- Highly Potent MRI Contrast Agent Displaying Outstanding Sensitivity to Zinc IonsAngewandte Chemie International Edition, 2020
- Structure–Relaxivity Relationships of Magnetic Nanoparticles for Magnetic Resonance ImagingAdvanced Materials, 2019
- Anchoring Group Effects of Surface Ligands on Magnetic Properties of Fe3O4 Nanoparticles: Towards High Performance MRI Contrast AgentsAdvanced Materials, 2014
- Inorganic Nanoparticles for MRI Contrast AgentsAdvanced Materials, 2009
- Synthesis and Relaxometric Studies of a Dendrimer‐Based pH‐Responsive MRI Contrast AgentChemistry – A European Journal, 2008